Clinical trials recruiting for Atherosclerosis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
  NCT05365438 · Phase: Phase 4 · Ages: 20 Years to 80 Years · Sex: All (male and female) · 1 location
• Cardiometabolic Risk Factors Registry
  NCT04040777 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
  NCT07611747 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 34 locations
• Causes and Natural History of Dyslipidemias
  NCT00353782 · Phase: Not specified · Ages: 2 Years to 100 Years · Sex: All (male and female) · 1 location
• Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
  NCT01143454 · Phase: Not specified · Ages: 1 Year to 100 Years · Sex: All (male and female) · 3 locations
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
  NCT05488431 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 3 locations
• Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
  NCT05365425 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
  NCT07719894 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Clopidogrel Versus Cilostazol on Vessels
  NCT06402747 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
  NCT05708859 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV
  NCT06560840 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
  NCT06488105 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry
  NCT06325800 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
  NCT05325034 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 22 locations
• Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
  NCT07524101 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 85 Years · Sex: All (male and female) · 2 locations
• New Heart Imaging Techniques to Evaluate Possible Heart Disease
  NCT01399385 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
  NCT06694012 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
  NCT07614230 · Phase: Phase 4 · Ages: 18 Years to 78 Years · Sex: All (male and female) · 2 locations
• Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
  NCT05180942 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 12 locations
• Study of the Effect of Innate on the Inflammatory Response to Endotoxin
  NCT01143480 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Text Education About Cardiovascular Health and HIV (TEACH-HIV)
  NCT05642858 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Atherosclerosis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Atherosclerosis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.